Sox10+ adult stem cells contribute to biomaterial encapsulation and microvascularization. by Wang, Dong et al.
UCLA
UCLA Previously Published Works
Title



















eScholarship.org Powered by the California Digital Library
University of California
1Scientific RepoRts | 7:40295 | DOI: 10.1038/srep40295
www.nature.com/scientificreports
Sox10+ adult stem cells contribute 
to biomaterial encapsulation and 
microvascularization
Dong Wang1,2,3,*, Aijun Wang1,4,*, Fan Wu1, Xuefeng Qiu1,3,5, Ye Li6,7, Julia Chu1,  
Wen-Chin Huang1, Kang Xu1,3, Xiaohua Gong2 & Song Li1,3
Implanted biomaterials and biomedical devices generally induce foreign body reaction and end up 
with encapsulation by a dense avascular fibrous layer enriched in extracellular matrix. Fibroblasts/
myofibroblasts are thought to be the major cell type involved in encapsulation, but it is unclear 
whether and how stem cells contribute to this process. Here we show, for the first time, that Sox10+ 
adult stem cells contribute to both encapsulation and microvessel formation. Sox10+ adult stem cells 
were found sparsely in the stroma of subcutaneous loose connective tissues. Upon subcutaneous 
biomaterial implantation, Sox10+ stem cells were activated and recruited to the biomaterial scaffold, 
and differentiated into fibroblasts and then myofibroblasts. This differentiation process from Sox10+ 
stem cells to myofibroblasts could be recapitulated in vitro. On the other hand, Sox10+ stem cells 
could differentiate into perivascular cells to stabilize newly formed microvessels. Sox10+ stem cells 
and endothelial cells in three-dimensional co-culture self-assembled into microvessels, and platelet-
derived growth factor had chemotactic effect on Sox10+ stem cells. Transplanted Sox10+ stem cells 
differentiated into smooth muscle cells to stabilize functional microvessels. These findings demonstrate 
the critical role of adult stem cells in tissue remodeling and unravel the complexity of stem cell fate 
determination.
Biomaterials and biomedical devices have been widely used in clinical applications, such as drug releasing 
devices1,2, glucose sensors3, vascular grafts4,5, bone and cartilage grafts6,7. The implants generally induce foreign 
body reaction and end up with encapsulation with a thick avascular fibrous layer composed of dense extracellular 
matrix around implants1. Encapsulation can be detrimental to some medical devices including drug releasing 
systems and glucose sensors, which blocks the free movement of molecules between the devices and host tissues, 
thus impairs their performances. Much effort has been made to modify biomaterials to reduce capsular thickness 
and/or enhance angiogenesis for better integration into host tissues1,8–10. On the other hand, encapsulation could 
also be beneficial for some implants such as vascular, bone and cartilage grafts. Upon transplantation, host cells 
are recruited to the biomaterial grafts from surrounding tissues, form a capsule layer, and infiltrate into the grafts 
if they have a porous structure, which promotes their integration into host tissues6,11,12.
Although encapsulation is an important phenomenon, there are few studies on the cellular origins of encap-
sulation. Traditionally, fibroblasts are thought to be the major cells contributing to biomaterials encapsulation1. 
Encapsulation is a fibrosis process and it shares the common characteristics of organ fibrosis or scar formation: 
the accumulation of extracellular matrix and the degeneration of microvessels13. Most studies on cellular ori-
gins of fibrosis are from organ fibrosis14. For example, during skin wound healing and scar formation, fibro-
blasts are activated to proliferate, differentiate into myofibroblasts, secrete excessive extracellular matrix, express 
smooth muscle α -actin (ACTA2) and apply contractive force to close the wound14. Studies from organ fibrosis 
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also reported that perivascular cells were another important source of myofibroblasts15–19. However, the relation-
ship between fibroblasts and perivascular cells, and the involvement of other stem cells remain to be elucidated.
In recent years, several research groups including our laboratory reported that Sox10+ adult stem cells existed 
in multiple tissues including large blood vessels walls and surrounding tissues, which could be recruited to vas-
cular graft contributing to tissue remodeling5,20. We sought to investigate whether and how Sox10+ stem cells 
participate in biomaterials encapsulation in general. Here we showed that Sox10+ adult stem cells were found in 
the stroma of subcutaneous loose connective tissues. We utilized in vivo subcutaneous biomaterial implantation, 
in vitro stem cell culture, ex vivo tissue explant culture, in vivo stem cell transplantation and two-photon live 
animal microscopy experiments and showed that Sox10+ adult stem cells differentiated into fibroblasts at early 
stages of biomaterial implantation, and then differentiated into myofibroblasts contributing to encapsulation, or 
perivascular cells supporting angiogenesis. The same cell population can give rise to both fibrotic/capsule tissues 
and microvessels depending on local microenvironment, which demonstrates the critical role of adult stem cells 
in tissue remodeling and unravels the complexity of stem cell fate determination.
Results
Sox10+ cells were found in the stroma of subcutaneous loose connective tissues and activated 
upon biomaterial implantation. To investigate whether Sox10+ adult stem cells contribute to biomate-
rial encapsulation, we prepared poly(L-lactic acid) (PLLA) scaffold membranes (Fig. 1a) and implanted them 
into multiple subcutaneous spaces of rats (Fig. 1b). Immunostaining showed sparse Sox10+ cells (< 2%) and 
fibroblasts (~5%, expressing fibroblast-specific protein 1 (FSP1), a fibroblast marker) in the stroma of subcuta-
neous loose connective tissues before implantation (Fig. 1c; Figure S1). These Sox10+ cells did not express FSP1 
(Fig. 1c), suggesting that they were a different stromal cell population from fibroblasts. One-week post-implanta-
tion, we found many Sox10+ cells (~20%) around the scaffold, and more than 90% of them showed FSP1 expres-
sion (Fig. 1d,e). We found similar phenomena in the scaffolds implanted into multiple subcutaneous sites of rats 
(Fig. 1b). These results are consistent with the traditional knowledge that fibroblasts are activated to proliferate 
upon injury. In addition, it demonstrates the connection between Sox10+ cells and fibroblasts in vivo.
Sox10+ cells are a precursor of fibroblasts. To determine the relationship of Sox10+ and FSP1+ cells, 
we performed conventional primary fibroblasts culture. Subcutaneous loose connective tissues were harvested 
from normal rats, cut into small pieces and put into culture dishes in the medium supplemented with 10% fetal 
bovine serum (FBS). The cells migrated from the tissues and proliferated with a classic fibroblast cell shape. After 
one week of culture, the primary cells were passaged to new dishes and used for analysis. By immunostaining, we 
found that most of the cells were Sox10+/FSP1+ (Fig. 2a; Figure S2a), similar to the cells around implanted scaf-
folds (Fig. 1d). Considering that high concentration of FBS may induce cell differentiation quickly, we switched to 
a custom-made chick embryo extract (CEE) medium. We obtained a Sox10+ population in CEE medium, among 
which about 25% of cells expressed FSP1 (Fig. 2b,c; Figure S2b), suggesting that CEE medium could slow down 
the differentiation of Sox10+ cells.
To isolate single Sox10+/FSP1− cells from Sox10+/FSP1+ cells, we plated the mixed cell population at very low 
density (~100 cells per 100-mm dish), and found most of them could form colonies after 10-day culture in CEE 
medium (Figure S3). By immunostaining, we found that, some colonies consisted of all Sox10+/FSP1+ cells while 
others had all Sox10+ cells with gradient expression pattern of FSP1 as the lowest level in the center and the high-
est at the periphery (Fig. 2d–f; Figure S4). Mixture of these colonies were further passaged for additional analysis 
of single-cell colony formation in the medium with 10% FBS, which may induce spontaneous differentiation. 
We found that all colonies became FSP1+ cells with few Sox10+ ones after two passages (Figure S5), indicating 
that differentiated fibroblasts lost Sox10 expression. These results suggest that Sox10+ cells are a precursor of 
fibroblasts.
Sox10+ cells are multipotent stem cells. We further characterized the stem cell properties of Sox10+ 
cells in vitro. By quantitative real-time polymerase chain reaction, we found the cultured cells had high telomerase 
activity compared to wounded and normal tissue (Fig. 3a). By flow cytometry and immunostaining (Fig. 3b–e), 
we found Sox10+ cells expressed markers of mesenchymal stem cells, such as CD29, CD44, CD73, CD90 and 
Snail. They also expressed neural crest stem cell markers, P75 and nestin, but not c-Kit, ADAM12, CD146 or 
NG2. They did not express CD45 indicating that they were not derived from hematopoietic lineage. In specific 
induction media, Sox10+ cells could differentiate into chondrogenic (Alcian blue), osteogenic (Alizarin red) and 
adipogenic (Oil red) cells (Fig. 3f–h). In the medium with 10% FBS and 10 ng/ml transforming growth factor β 1 
(TGFβ 1), they differentiated into myofibroblasts (Vimentin+ and smooth muscle α -actin+/ACTA2+) and smooth 
muscle cells (SMCs) (ACTA2+, Calponin1/CNN1+, Myocardin+, Smoothelin+ and smooth muscle myosin heavy 
chain+/MYH11+) (Fig. 3i–n).
Taken together, these results suggest that there are Sox10+ adult stem cells in the stroma of subcutaneous loose 
connective tissues, which can be activated to proliferate and differentiate into fibroblasts at early stages of bioma-
terial implantation. They also have the potential to differentiate into myofibroblasts and SMCs in vitro.
Sox10+ adult stem cells contribute to both encapsulation and microvascularization after trans-
plantation in vivo. To further investigate Sox10+ adult stem cell fate in vivo, we performed stem cell trans-
plantation experiments. Our flow cytometry results showed that Sox10+ stem cells also expressed P75, which is 
a surface marker for neural crest stem cells and can be conveniently used for live cell sorting. Thus we used P75 
to further purify the population for the following experiments. The green fluorescent protein (GFP)+/Sox10+/
P75+ cells were isolated from the first passage of Sox10+ cells from the subcutaneous loose connective tissues 
of GFP-rats using P75 as the marker for magnetic cell separation, and were subsequently transplanted into the 
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Figure 1. The activation and recruitment of Sox10+ cells after subcutaneous scaffold implantation.  
(a) Scanning Electron Microscopy image of the electrospun PLLA scaffold membrane. Scale bar, 100 μ m.  
(b) Illustration of multiple subcutaneous scaffold implantation sites in a rat. (c,d) The cross sections of normal 
subcutaneous tissue (c) and implanted scaffold (d) were immunostained by the antibodies against stem cell 
marker Sox10 and fibroblast marker FSP1. Cell nuclei were stained by DAPI. Arrow, Sox10+ cells. Arrowhead, 
FSP1+ cells. Hollow arrowhead, Sox10+/FSP1+ cells. White dashed lines illustrate the boundary between the 
implanted scaffold and surrounding native tissue. Scale bar, 10 μ m. (e) Percentages of Sox10+ cells before and 
after scaffold implantation were quantified. Mean ± SD of n = 3 independent experiments of n = 9 sections for 
each group. Student’s t-test was performed to analyze significant differences between groups. **P < 0.01.
www.nature.com/scientificreports/
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subcutaneous space of immunodeficient mice by Matrigel plug assay. After two weeks, the Matrigel plugs were 
harvested for immunohistology. We found that, in the periphery of the Matrigel plug, the GFP+ cells were elon-
gated, aligned parallel to each other, had strong ACTA2 signal, and formed a capsule layer wrapping around the 
Matrigel plug, indicating that they had differentiated into myofibroblasts (Fig. 4a and b; Figure S6). It was a sur-
prise that, in the center of the Matrigel plug, the GFP+ cells formed tubular structures and also expressed ACTA2, 
suggesting that they might have differentiated into perivascular cells (Fig. 4a and c; Figure S6).
To further examine the role of Sox10+ stem cells in vascular regeneration, we performed Matrigel tube for-
mation assay and found GFP+/Sox10+/P75+ stem cells formed microvessels when co-cultured with vascular 
endothelial cells (Fig. 5a). By transwell cell migration assay, we found that they had a chemotactic response to 
Figure 2. Sox10+ cells as a precursor of fibroblasts. (a,b) Primary cells from rat subcutaneous connective 
tissues were cultured in the medium of 10% FBS (a) and CEE (b) and immunostained with the antibodies 
against Sox10 and FSP1. (c) Percentages of FSP1+ cells among the primary cells in the media of 10% FBS and 
CEE. (d,e) The cells of a colony cultured in CEE medium were immunostained with the antibodies against 
Sox10 and FSP1. (f) Percentages of FSP1+ cells from the colony center to periphery. Arrow, Sox10+ cells. 
Arrowhead, FSP1+ cells. Hollow arrowhead, Sox10+/FSP1+ cells. Mean ± SD of n = 3 independent experiments 
of n = 9 fields for each group. Student’s t-test was performed to analyze significant differences between groups. 
**P < 0.01. Scale bar, 20 μ m.
www.nature.com/scientificreports/
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platelet-derived growth factor BB (PDGF-BB), an important growth factor involved in microvessel formation 
(Fig. 5b). In an ex vivo three-dimensional tissue explant culture model, Sox10+ cells co-migrated with vascular 
endothelial cells and newly sprouting microvessels (Fig. 5c). Thus, in vivo, in vitro and ex vivo results showed that 
Sox10+ adult stem cells contributed to both encapsulation and microvascularization.
We also examined other vascular markers of GFP+ vessels in the center of Matrigel plug and found GFP+ 
mural cells wrapped around CD31+ endothelial cells, expressed NG2 and MYH11 (Fig. 6a–c; Figure S7). It was 
interesting that these GFP+ microvessels had uniform expression of ACTA2 and NG2, but had a mosaic pattern 
of MYH11 expression (Figs 4 and 6; Figure S7), suggesting that they were in the process of maturation into SMCs. 
To examine whether the microvessels formed by GFP+/Sox10+ stem cells are functional, we implanted them into 
the skinfold chamber of immunodeficient mice (Figure S8) and imaged them by two-photon microscopy. By tail 
vein injection of Dextran-Rhodamine, we found the microvessels formed by GFP+ cells were perfused with the 
dye and thus were functional (Fig. 6d).
Fibroblast as an intermediate cell type in the process of perivascular cell maturation. To 
investigate the cell fate decision between fibroblasts and vascular mural cells, we performed immunostain-
ing of GFP+ microvessels in the Matrigel plug. We found that the GFP+ cells lost Sox10 expression two-week 
post-implantation. There were GFP+/ACTA2+/FSP1+ mural cells in some microvessels (Fig. 7a), but some GFP+/
ACTA2+ mural cells already lost FSP1 expression (Fig. 7b). To investigate the temporal dynamics of FSP1 expres-
sion, we induced Sox10+ stem cells to differentiate into SMCs in vitro as mentioned before (Fig. 3i–n). We found 
that most of the cells expressed FSP1 with or without ACTA2 expression (FSP1+/ACTA2−, or FSP1+/ACTA2+) at 
early stages (3 days), however at late stages (14 days), most of the cells were FSP1−/ACTA2+ and only a few FSP1+ 
cells remained (Fig. 7c,d). These results suggest that FSP1+ mural cells may be an intermediate cell type during 
perivascular cell maturation.
Figure 3. Multipotency of Sox10+ cells. (a) Telomerase activity assay was performed on the native 
subcutaneous tissue (Control, without injury), wounded tissue and primary cells. Mean ± SD of n = 3 
independent experiments for each group. Student’s t-test was performed to analyze significant differences 
between groups. *P < 0.05. (b) Flow cytometry analysis of primary Sox10+ cells with the antibodies against 
CD29, CD44, CD73, CD90, P75, c-Kit, ADAM12, CD146 and CD45. (c–e) The primary Sox10+ cells were 
immunostained by the antibodies against NG2 (c), Nestin (d) and Snail (e). (f–n) After culture in specific 
differentiation media, the cells were stained by Alcian blue (f), Alizarin red (g), Oil red (h) and antibodies 
against Vimentin (i), ACTA2 (j), CNN1 (k), Myocardin (l), Smoothelin (m) and MYH11 (n). Cell nuclei were 
stained by DAPI. Scale bar, 20 μ m.
www.nature.com/scientificreports/
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Discussion
Previous studies show that Sox10 is a marker of neural crest cells during embryonic development, which give 
rise to most craniofacial tissues including connective tissues and vascular SMCs21,22. In recent years, Sox10+ stem 
cells have been reported to exist in multiple adult tissues, including inferior turbinate23, periodontal ligament24, 
hair follicle25,26, mammary epithelium27, and bone marrow28. Sox10 could also promote tumor formation29. In 
our previous work, Sox10+ adult stem cells were found in large blood vessel walls and surrounding tissues, and 
were recruited to vascular grafts contributing to vascular remodeling5,20,30. In this study, we further demonstrate 
that Sox10+ stem cells have a more universal distribution and can be found in the stroma of subcutaneous loose 
connective tissues, which could contribute to both encapsulation/fibrosis and microvascularization. Our studies, 
together with others, indicate that Sox10+ stem cells play important roles in adult tissue remodeling.
Although biomedical devices have been widely used in clinical applications, there remains a high failure rate9. 
Encapsulation is one of the major factors that cause the failure of implanted devices1,9. Most research groups have 
been focusing on modifying biomaterial composition, surface, structure or morphology to reduce capsule thick-
ness and/or enhance angiogenesis1,9,10. On the contrary, some other research groups harnessed biomaterial encap-
sulation to make tubular structures composed of fibrous capsule tissues as vascular grafts31. Given the importance 
of biomaterial encapsulation, however, little attention has been paid on its cellular origins. Traditionally, fibro-
blasts are thought to be the major cells contributing to encapsulation, which is similar to skin wound healing 
and scar formation1,14. In this study, we found that Sox10+ adult stem cells in the stroma of subcutaneous loose 
connective tissues are a precursor of proliferating fibroblasts and myofibroblasts during encapsulation. Moreover, 
Sox10+ adult stem cells can contribute to microvascularization by differentiating into perivascular cells (Fig. 4). 
To our knowledge, this is the first report that a type of adult stem cells can directly contribute to both encapsula-
tion/fibrosis and microvascularization.
Myofibroblasts and vascular SMCs are similar as they both express ACTA2 and produce contractile force14,32. 
A distinction is their tissue locations, as myofibroblasts usually exist in dense connective tissues enriched in extra-
cellular matrix, while vascular SMCs wrap around blood vessels. It was reported that the ACTA2 gene expression 
was regulated differently in these two types of cells33. Some markers are used to separate these two cell types, such 
as MYH11 and Smoothelin, which are expressed in SMCs, but not in myofibroblasts34,35. However, it was also 
reported that differentiating myofibroblasts could express SMC markers CNN1, Smoothelin and MYH1136. Our 
study suggests that Sox10+ stem cells may go through a common fibroblast-like stage and further differentiate 
into myofibroblasts or SMCs, depending on the microenvironment.
At present, fibroblasts have not been well defined and previous observation and concept of fibroblasts might 
include cells at various stages of differentiation as they appear quite heterogeneous. They are mostly described 
based on cell morphology and their tissue location: they are embedded in the stroma of connective tissues, have 
a spindle shape, and are not vascular, epithelial or inflammatory cells37,38. A few markers have been proposed 
for identifying fibroblasts, including FSP1. It was first reported as a fibroblast marker by Strutz et al. and was 
found to be able to distinguish fibroblasts from epithelial cells39. FSP1 has also been used as an early marker for 
epithelial-mesenchymal transition and may play important roles during fibrosis39–42. Arteriole SMCs were found 
Figure 4. Sox10+ adult stem cells contribute to both encapsulation and microvascularization. (a) The 
cross section of the Matrigel plug with GFP+ cells was immunostained by the antibody against ACTA2. Cell 
nuclei were stained by DAPI. The dashed curve outlines the capsule layer around the Matrigel plug. (b,c) The 
zoomed-in images of the two dashed squares in a (c, orthogonal view). Scale bar, 10 μ m.
www.nature.com/scientificreports/
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to express FSP1 in benign nephrosclerosis samples and thought to contribute to fibrosis process43. In contrast to 
the traditional opinion that FSP1 expression is indicative of fibrosis, our results showed that FSP1+ cells still retain 
the capability of forming microvessels. This result is consistent with the reports that FSP1 protein could promote 
angiogenesis during tumor formation44–46 and fibroblasts could stabilize in vitro engineered microvessels47. In 
our stem cell transplantation experiment in vivo, GFP+/Sox10+ stem cells differentiated into two types of perivas-
cular cells: FSP1+/ACTA2+ and FSP1−/ACTA2+. During Sox10+ stem cells’ differentiation into SMCs in vitro, 
FSP1 expression was decreased in the late stages. These results indicate that FSP1 might be an intermediate stage 
marker during the differentiation of Sox10+ stem cells into perivascular cells or SMCs.
As encapsulation/fibrosis and microvascularization lead to distinct clinical outcomes, understanding the 
underlying regulatory mechanisms is of great importance. These two processes seem to compete with each other 
during tissue regeneration, as encapsulation/fibrosis is usually accompanied by microvascular degeneration1,13. 
However, there is evidence that the cells involved in these two processes may be related. For example, pericytes 
or perivascular progenitor cells17–19 and SMCs43 have been reported to give rise to myofibroblasts during fibrosis. 
On the other hand, there has also speculation that myofibroblasts, when put in the right microenvironment, such 
as the media layer of large blood vessel walls, might differentiate into SMCs35, suggesting the possibility of recip-
rocal transformation of the two processes. Our study showed that even the cells expressing FSP1, a traditionally 
recognized fibroblast/fibrosis marker, could form microvessels. The microenvironment of the cells (in this study, 
cell location relative to a Matrigel plug) probably played a key role in cell fate determination.
In conclusion, this study provides a novel mechanism that Sox10+ adult stem cells in the stroma of subcutane-
ous loose connective tissues are a common precursor of fibroblasts/myofibroblasts and perivascular cells. These 
adult stem cells can first differentiate into fibroblast-like cells at early stages of biomaterials implantation, and then 
into myofibroblasts promoting encapsulation/fibrosis, or perivascular cells supporting microvessels. This study 
is focused on Sox10+ adult stem cells and their functions in encapsulation/fibrosis and microvessel regeneration. 
Figure 5. Sox10+ cells contribute to microvessel formation in vitro. (a) GFP+/Sox10+/P75+ stem cells and 
vascular endothelial cells were co-cultured on Matrigel and immunostained by the antibody against CD31. 
Arrow, GFP+ cells. (b) Chemotaxis assay (transwell cell migration) of GFP+/Sox10+/P75+ stem cells to bFGF, 
PDGF-BB and VEGF. Mean ± SD of n = 3 independent experiments of n = 9 wells for each group. Student’s 
t-test was performed to analyze significant differences between groups. **P < 0.01. (c) Ex vivo tissue explant 
culture sample was stained by the antibodies against Sox10 and CD31. Arrow, Sox10+ cells. Cell nuclei were 
stained by DAPI. Scale bar, 10 μ m.
www.nature.com/scientificreports/
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Indeed, this complex remodeling process also involves other cell types such as inflammatory, microvascular and 
other types of stem cells. Further studies are warranted to investigate how different cells, extracellular matrices 
as well as other microenvironmental factors interact with each other to determine cell fate in tissue remodeling.
Materials and Methods
Fabrication of biomaterial scaffold membrane. Microfiber scaffold membranes were fabricated by 
using PLLA (MW 67,400, Sigma Aldrich) as previously reported5,48. The polymer was completely dissolved in 
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP, Aladdin) at the concentration of 19% (w/v). Microfibrous scaffold 
were made by electrospinning. The negative voltage of 4.5 kV was applied to the collecting plate, and a positive 
voltage of 4 kV was applied to the spinneret by using a high-voltage generator (Gamma High Voltage, Ormond 
Beach, FL). The electrospinning process was allowed to proceed until an approximately 200 μ m wall thickness 
was achieved. The structure of the scaffolds was characterized by using a scanning electron microscope (Hitachi 
TM-1000).
Animal experiments. All the animal procedures in this study followed the National Institutes of Health 
guide for the care and use of Laboratory animals and were approved by the University of California Berkeley 
Animal Care and Use Committee. For rats, anesthesia was induced with 3% isoflurane in an induction cham-
ber followed by subcutaneous injection of 0.05 mg/kg buprenorphine and 1 mg/kg meloxicam for analgesia. For 
mice, anesthesia was induced with 3% isoflurane in an induction chamber followed by subcutaneous injection 
of 0.1 mg/kg buprenorphine and 5 mg/kg meloxicam for analgesia. Maintenance anesthesia was with 1.5–2% 
isoflurane delivered by mask. Toe pinch was performed to confirm the anesthetic depth. Aseptic surgeries were 
performed in all the procedures. Post-surgery buprenorphine was given to the animals for analgesia. The body 
weight, appearance and appetite of the animals will be monitored every day. The animals were euthanized by CO2 
inhalation until they ceased breathing completely and then followed by bilateral thoracotomy for rats, or cervical 
dislocation for mice. The samples were then collected for analysis.
Subcutaneous biomaterials implantation: Male Sprague Dawley (SD) rats with the body weight of about 100–
150 g were used in the experiments. Small pieces of PLLA membrane (about 5 × 5 mm) were implanted into 
Figure 6. Sox10+ adult stem cells contribute to functional microvessels. (a–c) The cross sections of Matrigel 
plug with GFP+ cells were immunostained with the antibodies against CD31 (a), NG2 (b) and MYH11 (c).  
(d) Two-photon image of mouse dorsal skinfold chamber transplanted with GFP+/Sox10+ stem cells. Dextran-
Rhodamine was injected into the mouse through tail vein before imaging. Cell nuclei were stained by DAPI. 
Arrow, GFP+ cells. Arrowhead, double positive cells. Scale bar, 10 μ m.
www.nature.com/scientificreports/
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various subcutaneous spaces, such as abdomen, neck, groin and back. Normal SD rats of the same body weight 
were used as a control group. Each group had three animals.
Matrigel plug assay: Sox10+ stem cells were isolated from GFP-rats (Rat Resource & Research Center, # 0065), 
and the first passage of cells were used for isolating GFP+/Sox10+/P75+ cells by P75 magnetic cell separation 
(MACS kit, Miltenyi Biotec, 130-097-127) according to the product instructions. The GFP+/Sox10+/P75+ cells 
were then mixed with Matrigel (Corning) with the cell density of 2 × 106/ml and then injected to immunodefi-
cient NSG mice (The Jackson Laboratory, # 005557) subcutaneously. After two weeks, the Matrigel plugs were 
harvested for histological analysis.
Mouse dorsal skinfold chamber: The procedure for implanting dorsal skinfold chamber was described 
previously49, with minor modifications. The GFP+/Sox10+/P75+ stem cells prepared as mentioned above 
were mixed with Matrigel and injected into the skinfold chamber of NSG mice by a curved 30 G needle. For 
two-photon microscopy, the mice were anesthetized by isoflurane and placed on a custom-made stage for imag-
ing. One hour before imaging, dextran-Rhodamine was injected to the mice through tail vein. The z-series images 
were taken at the wavelength of 890 nm.
Cell culture, telomerase activity and differentiation. Sox10+ adult stem cells were isolated from sub-
cutaneous loose connective tissue of SD rats or transgenic GFP-rats. Subcutaneous loose connective tissues were 
dissected and cut into small pieces and placed onto the culture dish coated with 1% CellStart (Invitrogen) to allow 
cells to migrate out of the tissue explants. The culture was maintained in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 10% FBS, or in an optimized CEE medium, which is composed of DMEM supple-
mented with 2% CEE (MP Biomedical), 2% FBS, 1% N2 (Invitrogen), 2% B27 (Invitrogen), 100 nM retinoic acid 
(Sigma-Aldrich), 50 nM 2-mercaptoethanol (Sigma-Aldrich), 1% Penicillin/Streptomycin and 20 ng/ml bFGF 
(R&D Systems) based on a previous established protocol19. Telomerase activity was performed by a Quantitative 
Figure 7. FSP1 expression during microvessel formation. (a,b) Orthogonal views of the cross sections of 
the Matrigel plug with GFP+ cells, which were immunostained by the antibodies against ACTA2 and FSP1. 
Scale bar, 10 μ m. Arrowhead, GFP+/ACTA2+/FSP1+ cells. Arrow, GFP+/ACTA2+ cells. (c) Sox10+ stem cells 
were cultured in the medium with 10% FBS and 10 ng/ml TGFβ 1 for 3 and 14 days, and immunostained by 
antibodies against ACTA2 and FSP1. Cell nuclei were stained by DAPI. Scale bar, 100 μ m. Hollow arrowhead, 
FSP1+ cells. Arrowhead, ACTA2+/FSP1+ cells. Arrow, ACTA2+ cells. (d) Percentages of different cell 
populations were quantified. Mean ± SD of n = 3 independent experiments of n = 12 fields for each group. 
Student’s t-test was performed to analyze significant differences between groups. **P < 0.01.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7:40295 | DOI: 10.1038/srep40295
Telomerase Detection kit (US Biomax) according to the manufacturer instructions. For differentiation into fibro-
blasts, the cells were cultured in DMEM supplemented with 10% FBS. For differentiation into myofibroblasts and 
SMCs, the cells were cultured in DMEM supplemented with 10% FBS and 10 ng/ml TGFβ 1 (Peprotech) for two 
weeks. For differentiation into chondrogenic, osteogenic and adipogenic cells, the cells were cultured in specific 
media as described previously20,50.
Flow cytometry analysis. For flow cytometry analysis, the Sox10+ stem cells were detached by 0.2% ethyl-
enediaminetetraacetic acid (EDTA) for about 10 min, and blocked in 1% bovine serum albumin (BSA) for 30 min 
on ice. The following primary antibodies were used: CD29 (555005, BD), CD44 (550974, BD), CD73 (551123, 
BD), CD90 (554898, BD), P75 (ab8874, Abcam), c-Kit (sc-1494, Santa Cruz Tech), CD146 (FAB3250F, R&D), 
CD45 (561867, BD), ADAM12 (14139-1-AP, Proteintech Group Inc.). For unconjugated primary antibodies, 
corresponding secondary antibodies were used. Isotype IgG was used as negative control. Propidium iodide was 
used to exclude dead cells. A Guava easyCyte™ Flow Cytometer was used for the analysis.
Single-cell colony formation assay. Sox10+ cells were detached and suspended in CEE medium. About 
100 cells were added to each 100-mm dish in CEE medium. Medium was changed every three days. For secondary 
and tertiary single-cell colony formation in the medium of 10% FBS, the cells of single colonies were first washed 
with phosphate buffered saline (PBS), 8-mm glass cylinders with grease (Dow Corning 976 V High-Vacuum 
grease) on the bottom side were placed around the colonies, and TrypLE (Invitrogen) was added into the cylin-
ders to detach the cells. The mixture of single colonies were passaged to new dishes at the density of about 100 
cells per 100-mm dish in the medium with 10% FBS.
Transwell cell migration assay. 24-well transwell plates (Costar, pore size: 8 μ m) were used for the cell 
migration assay. For each well, 4 × 104 GFP+/Sox10+/P75+ stem cells isolated as mentioned above were seeded 
onto the top insert for 2 h in DMEM supplemented with 0.5% BSA. The top inserts were then transferred to the 
wells with DMEM supplemented with 0.5% BSA (control) and specific growth factors: 10 ng/ml basic fibroblast 
growth factor (bFGF), platelet-derived growth factor BB (PDGF-BB) and vascular endothelial growth factor 
(VEGF). After 5 h, the cells were fixed, stained by DAPI and the migrating cells numbers were counted by confo-
cal microscopy. There were three repeats for each group.
Matrigel tube formation assay. GFP+/Sox10+/P75+ stem cells isolated as mentioned above were mixed 
with human microvascular endothelial cells (HMECs) (ratio: 0.3:1) and seeded onto the surface of Matrigel 
(Corning). The cells were fixed for immunostaining after overnight culture in EGM2 medium (Lonza).
Ex vivo tissue explant culture models. Rat subcutaneous connective tissue was cut into small pieces and 
placed in collagen I (1 mg/ml, Millipore) gel. The culture medium was Opti-MEM (Invitrogen) supplemented 
with 20 ng/ml bFGF.
Histology and immunostaining. Rat and mouse tissues and biomaterial samples were collected and fixed 
in 4% paraformaldehyde for half hour at room temperature. The animal tissue samples were then transferred to 
15% and 30% sucrose overnight in cold room, and embedded in OCT for cryosection. For immunostaining, the 
cells were fixed with 4% paraformaldehyde for 15 min, the tissue sections were re-fixed with 4% paraformalde-
hyde for 10 min, before permeabilized in 0.5% Triton X-100 (Sigma-Aldrich) for 5 min. The samples were then 
blocked with 5% donkey serum for 1 h, incubated in primary antibodies for 2 h at room temperature, or overnight 
at cold room. The following primary antibodies were used: MYH11 (BT-562, Biomedical Technologies), CD31 
(ab28364, abcam), Sox10 (sc-17342, Santa Cruz Biotech), Snail (sc-28199, Santa Cruz Tech), Tuj1 (MAB1637, 
EMD Millipore), NG2 (AB5320, EMD Millipore), ACTA2 (ab32575, abcam), FSP1 (ab27957, abcam), Vimentin 
(ab92547, abcam), Calponin1 (CNN1, ab46794, abcam), Smoothelin (sc-28562, Santa Cruz Tech), Myocardin 
(sc-34238, Santa Cruz Tech). After primary antibodies incubation, the samples were washed with 0.1% Triton for 
three times, incubated with corresponding AF488, 546 or 633-labeled secondary antibodies (Molecular Probes) 
and 4′ ,6-diamidino-2-phenylindole (DAPI). Fluorescence images were taken by confocal microscopy (Prairie, 
Zeiss LSM710 and Leica SP5-Blue). Nine cross sections were used to count Sox10+ cell number in normal tissue 
and around scaffold. For counting FSP1+ and ACTA2+ cells cultured in the media of CEE, 10% FBS and 10% 
FBS plus TGFβ 1, at least nine fields of view were collected for each group. The figures were processed by Adobe 
Photoshop and Adobe Illustrator.
Statistical analysis. Data were reported as means ± SD, unless otherwise indicated. All experiments were 
repeated at least three times. Student’s t-test was used for the analysis of differences between different groups. 
Significance level was set as P < 0.05 or 0.01.
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